Roper Technologies (ROP) to Divest CIVCO Radiotherapy

Go back to Roper Technologies (ROP) to Divest CIVCO Radiotherapy

Roper Technologies (ROP) Sells CIVCO Radiotherapy to Blue Wolf Capital

October 22, 2021 7:00 AM EDT

Blue Wolf Capital Partners LLC (Blue Wolf), a New York-based private equity firm, today announced it has entered into an agreement to acquire CIVCO Radiotherapy, a global leader of radiotherapy patient positioning and immobilization equipment, from Roper Technologies, Inc. (NYSE: ROP).

With a nearly 40-year operating history and a track record of quality and reliability, CIVCO Radiotherapy serves a blue-chip customer base of academic and community hospitals, cancer centers and OEM manufacturers. CIVCO Radiotherapy is... More

Roper Technologies (ROP) Tops Q3 EPS by 8c

October 22, 2021 6:58 AM EDT

Roper Technologies (NYSE: ROP) reported Q3 EPS of $3.91, $0.08 better than the analyst estimate of $3.83. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.61 billion.

GUIDANCE:

Roper Technologies sees FY2021 EPS of $15.26-$15.30, versus the consensus of... More